SCHEMBL337741

SCHEMBL337741

CCC(=O)C(=O)CC(C)=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.53
TDP1 Q9NUW8 3/20 0.53
MGAM O43451 1/20 0.41
GAA P10253 1/20 0.41
SI P14410 1/20 0.41
MGAM2 Q2M2H8 1/20 0.41
HTT P42858 1/20 0.38
FFAR3 O14843 2/20 0.37
KDM4E B2RXH2 1/20 0.36
KDM6B O15054 1/20 0.36
KDM5C P41229 1/20 0.36
EGLN1 Q9GZT9 1/20 0.36
PHF8 Q9UPP1 1/20 0.36
KDM2A Q9Y2K7 1/20 0.36
TRPA1 O75762 1/20 0.35
CES1 P23141 3/20 0.33
CES2 O00748 2/20 0.33
CA1 P00915 2/20 0.33
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11223569 0.87 MGAM (0.50) ALDH1A1TDP1MGAMGAASI
SCHEMBL12899213 0.83 MGAM (0.47) ALDH1A1TDP1MGAMGAASI
SCHEMBL108375 0.79
Butanone SCHEMBL5471831 0.76 ALDH1A1 (0.77) ALDH1A1TDP1MGAMGAASI
SCHEMBL1763371 0.75 FFAR3 (0.53) ALDH1A1TDP1FFAR3CES1CES2
SCHEMBL3629363 0.73
SCHEMBL8723151 0.73 CA4 (0.56) ALDH1A1TDP1FFAR3CA1HDAC3
SCHEMBL10481675 0.73 MGAM (0.39) ALDH1A1TDP1MGAMGAASI
SCHEMBL9400331 0.73
Butanone SCHEMBL8379087 0.71 ALDH1A1 (1.00) ALDH1A1TDP1MGAMGAASI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 271 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119120251-B Probiotic freeze-dried powder and preparation method thereof 湖南省青耕生物产业创新研究院有限公司 2025-03-25 CN claimed
CN-119120251-A Probiotic freeze-dried powder and preparation method thereof 湖南省青耕生物产业创新研究院有限公司 2024-12-13 CN claimed
US-8535430-B2 Hydrazine filtration method and system NEW MEXICO HIGHLANDS UNIVERSITY (US) 2013-09-17 US claimed
US-20130196358-A1 METHOD FOR THE DIAGNOSIS OF AMYOTROPHIC LATERAL SKLEROSIS STEFFAN BERT (DE) 2013-08-01 US claimed
EP-1797947-B1 Encapsulated active material with reduced formaldehyde potential INT FLAVORS & FRAGRANCES INC (US) 2013-03-27 EP claimed
EP-2569638-A1 METHOD FOR THE DIAGNOSIS OF AMYOTROPHIC LATERAL SKLEROSIS MetaLab GmbH (DE) 2013-03-20 EP claimed
EP-2545988-A2 Encapsulated active material with reduced formaldehyde potential International Flavors & Fragrances, Inc. (US) 2013-01-16 EP claimed
US-8097074-B2 Air filtration and absorption method and system for the remediation of hydrazine NEW MEXICO HIGHLANDS UNIVERSITY (US) 2012-01-17 US claimed
WO-2011141519-A1 METHOD FOR THE DIAGNOSIS OF AMYOTROPHIC LATERAL SKLEROSIS METALAB GMBH (DE) 2011-11-17 WO claimed
US-20110194988-A1 HYDRAZINE SPILL PAD APPARATUS AND METHOD OF MANUFACTURING NEW MEXICO HIGHLANDS UNIVERSITY 2011-08-11 US claimed
US-20110182780-A1 HYDRAZINE FILTRATION METHOD AND SYSTEM NEW MEXICO HIGHLANDS UNIVERSITY 2011-07-28 US claimed
US-20110011266-A1 AIR FILTRATION AND ABSORPTION METHOD AND SYSTEM FOR THE REMEDIATION OF HYDRAZINE NEW MEXICO HIGHLANDS UNIVERSITY 2011-01-20 US claimed
US-20110010878-A1 HYDRAZINE DECONTAMINATION WIPES NEW MEXICO HIGHLANDS UNIVERSITY 2011-01-20 US claimed
US-20090258042-A1 Encapsulated Active Materials Containing Adjunct Crosslinkers INTERNATIONAL FLAVORS & FRAGRANCES INC. 2009-10-15 US claimed
WO-2009103615-A1 IMPROVEMENTS RELATING TO BENEFIT PARTICLES UNILEVER PLC (GB) 2009-08-27 WO claimed
US-20070138671-A1 Encapsulated active material with reduced formaldehyde potential INTERNATIONAL FLAVORS & FRAGRANCES INC. 2007-06-21 US claimed
US-20070138674-A1 ENCAPSULATED ACTIVE MATERIAL WITH REDUCED FORMALDEHYDE POTENTIAL INTERNATIONAL FLAVORS & FRAGRANCES INC. 2007-06-21 US claimed
EP-1797947-A2 Encapsulated active material with reduced formaldehyde potential INTERNATIONAL FLAVORS & FRAGRANCES, INC. (US) 2007-06-20 EP claimed
US-5169961-A Process for the production of 2-acetylbenzo [β]thiophenes ABBOTT LABORATORIES (US) 1992-12-08 US claimed
US-4721642-A Article having adhered, velvety polyurethane resin foam-coated pile as a surface decoration TOYODA GOSEI CO., LTD. (JP) 1988-01-26 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090258042-A1 Encapsulated Active Materials Containing Adjunct Crosslinkers CAPG, ANXA5, CD68 ALDH1A1 1313/4885TDP1 3206/4885MGAM 270/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.